ArticleBiotechnology letters2026
Edible layered double hydroxide nanoparticles on 3D scaffolds for accelerated biological cell development.
Article in Biotechnology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
By 2050, surging global population will intensify food insecurity, making it imperative to develop innovative strategies that boost plant productivity. Plants are our core food supply. Engineered nanoparticles have emerged as promising growth stimulants; however, carbon nanotubes (CNTs), despite their efficacy, are inedible and pose eco-toxicity concerns that restrict their agrobiological deployment. Furthermore, conventional whole-tissue studies obscure individual cell responses, preventing precise characterization of nanoparticle-cell interactions. Here, we introduce magnesium-aluminium layered double hydroxide (MgAl-LDH) nanoparticles, which is a food-grade material derived from commercial antacid formulations, that outperformed CNTs in accelerating plant cell development. This enhancement is suggested to be associated with the presence of magnesium ions and the positively charged LDH surface architecture, although the detailed molecular mechanisms remain to be fully elucidated.
Indexed as
Identifiers
42771272What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.